If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

文章核心观点 - 文章作者Edmund Ingham是一位拥有超过5年经验的生物技术顾问 专注于生物技术、医疗保健和制药行业 并已汇编了超过1,000家公司的详细报告 [1] - 作者领导一个名为Haggerston BioHealth的投资研究小组 该小组面向生物技术投资的新手和经验丰富的投资者 提供需关注的市场催化剂、买卖评级、大型制药公司的产品销售与预测、综合财务报表、贴现现金流分析以及按市场细分分析等服务 [1] 作者背景与服务平台 - 作者通过其投资研究小组Haggerston BioHealth提供每周通讯订阅 旨在帮助投资者了解生物技术、制药和医疗保健行业内股价变动的股票 并把握推动估值的关键趋势和催化剂 [1]

The biotech's chief legal and financial officers were among four executives who sold shares on the same day. ...

Cybin Inc. ( CYBN ) stock is one that has failed to kick on in 2025, despite having a couple late stage assets in CYB003 and CYB004. And whilst over the past month shares have seenI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind dru ...

Raanana, Israel, Jan. 02, 2026 (GLOBE NEWSWIRE) -- As the 2025-2026 flu season intensifies across the United States, a mutated strain of influenza A is driving most cases, sparking concerns about a potentially tough winter ahead. According to the latest CDC estimates (as of late December 2025), flu has already caused at least 4.6 million illnesses, 49,000 hospitalizations, and 1,900 deaths nationwide. Flu activity is rising sharply, with outpatient visits for influenza-like illness well above baseline in ma ...

Immatics N.V. (NASDAQ:IMTX – Get Free Report) shot up 3.9% on Wednesday . The stock traded as high as $10.42 and last traded at $10.4630. 130,449 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 764,094 shares. The stock had previously closed at $10.07. Get Immatics alerts: Wall Street Analyst Weigh InIMTX has been the subject of several recent research reports. Chardan Capital reissued a “buy” rating and set a $25.00 price target on shares of Immatics in a res ...

What happenedAccording to a November 14, 2025 SEC filing, HighVista Strategies LLC initiated a new stake in Cidara Therapeutics (CDTX +0.04%), acquiring 70,904 shares worth $6.79 million as of September 30, 2025. This new holding accounts for 1.66% of the fund’s reportable U.S. equity assets for the quarter. The fund reported a total of 148 reportable positions at quarter-end.What else to knowThis is a new position; the $6.79 million stake makes up 1.66% of HighVista Strategies LLC’s 13F reportable AUM as o ...

文章核心观点 - 生物科技行业呈现出科学前景与公司财务脆弱性并存的二元性 [1] - 作者专注于高增长、具有指数级扩张潜力的行业和公司 其投资方法结合基本面分析与未来趋势预测 并相信创新能带来丰厚回报 [1] 作者背景与立场 - 作者自称对高增长公司有强烈倾向 擅长投资颠覆性技术和前瞻性企业 [1] - 文章内容基于作者个人观点 作者未因撰写本文获得除Seeking Alpha平台外的任何报酬 [2] - 作者在文章发布时及未来72小时内 未持有任何所提及公司的股票、期权或类似衍生品头寸 也无相关建仓计划 [2] - 作者与文中提及的任何公司均无业务关系 [2] 平台声明 - 本文观点不代表Seeking Alpha整体立场 [3] - Seeking Alpha并非持牌证券交易商、经纪商、美国投资顾问或投资银行 [3] - 平台分析师为第三方作者 包括专业投资者和个人投资者 他们可能未获得任何机构或监管机构的许可或认证 [3]

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the definitive coming-out party for the genomic revolution. PACB stock is up. See the chart and price action here. As 2025 draws to a close, ARK aggressively trimmed legacy winners such as Tesla, Inc. (NASDAQ:TSLA) and Rocket Lab Corp. (NASDAQ:RKLB) to fund a multi-million dollar accumulation of gene-editing pioneers. Read Next: Palantir: From Meme Stock To Market Leader In 2025 ARK Invest has been speci ...

美股市场表现 - 美股周三盘中走低 道琼斯指数下跌超过100点[1] - 道琼斯指数下跌0.28%至48,229.87点 纳斯达克指数下跌0.26%至23,359.33点 标普500指数下跌0.26%至6,878.07点[1] - 公用事业板块下跌0.2% 房地产板块下跌0.8%[1] 商品市场动态 - 原油价格上涨0.1%至每桶58.02美元[5] - 黄金价格下跌0.8%至每盎司4,351.00美元[5] - 白银价格下跌7.3%至每盎司72.255美元 铜价下跌1.9%至每磅5.6710美元[5] 全球股市概览 - 欧洲股市普遍下跌 欧元区STOXX 600指数下跌0.14% 西班牙IBEX 35指数下跌0.27% 英国富时100指数下跌0.09% 法国CAC 40指数下跌0.23%[6] - 亚洲市场涨跌互现 香港恒生指数下跌0.87% 中国上证综指上涨0.09% 印度BSE Sensex指数上涨0.64%[7] 个股异动情况 - Anghami Inc (NASDAQ:ANGH) 股价飙升50%至3.7306美元 因公司上半年业绩同比增长[9] - Vanda Pharmaceuticals Inc (NASDAQ:VNDA) 股价大涨32%至9.28美元 因公司宣布其药物NEREUS获得FDA批准用于预防晕动症引起的呕吐[9] - Intelligent Bio Solutions Inc (NASDAQ:INBS) 股价暴涨102%至8.27美元 因公司宣布与Syrma Johari MedTech达成战略制造合作伙伴关系[9] - Corcept Therapeutics Incorporated (NASDAQ:CORT) 股价暴跌52%至34.04美元 因公司宣布其药物Relacorilant收到FDA的完整回复函[9] - FuelCell Energy, Inc (NASDAQ:FCEL) 股价下跌10%至7.18美元 因公司提交了修订后的普通股发行申请[9] - SMX (Security Matters) Public Limited Company (NASDAQ:SMX) 股价下跌37%至32.30美元[9] 宏观经济数据 - 美国上周初请失业金人数减少16,000人至199,000人 低于市场预期的220,000人[10] - 美国上周（截至12月26日）战略石油储备以外的原油库存减少193.4万桶 为自11月中旬以来最大单周降幅 且降幅大于市场预期的90万桶[2][10]